keyword
https://read.qxmd.com/read/37784892/patient-reported-outcomes-following-palliative-whole-brain-radiation-therapy-in-patients-with-brain-metastasis
#21
JOURNAL ARTICLE
B C Adegboyega, A O Joseph, O A Alabi, J Omomila, L Ngema, V Ainsworth, J Chin, W Ngwa
PURPOSE/OBJECTIVE(S): Brain metastases (BM) are a common occurrence in patients with advanced cancers, and extremely challenging to treat, resulting in short survival periods. Consequently, whole brain radiation therapy (WBRT) remains the standard palliative intervention for patients with BM. The present study set to evaluate the efficacy of WBRT by assessing the quality of life (QoL) and survival outcomes in WBRT-treated patients with BM. It was hypothesized that the WBRT would enhance the QoL through alleviation of symptoms and functionality, and prolong patient survival...
October 1, 2023: International Journal of Radiation Oncology, Biology, Physics
https://read.qxmd.com/read/37751050/palliative-care-in-neuro-oncology-an-update
#22
REVIEW
John Y Rhee, Sumita Strander, Alyx Podgurski, Daniel Chiu, Kate Brizzi, Deborah A Forst
PURPOSE OF REVIEW: While the benefits of palliative care for patients with cancer are well established, palliative care in neuro-oncology is still in its early stages. However, in recent years, there has been increasing attention drawn to the need for better palliative care for patients with brain tumors. RECENT FINDINGS: There is a growing body of literature demonstrating the high symptom burden and significant supportive care and information needs of these patients and their caregivers...
September 26, 2023: Current Neurology and Neuroscience Reports
https://read.qxmd.com/read/37746263/editorial-365-days-of-progress-in-neuro-oncology-and-neurosurgical-oncology
#23
EDITORIAL
Erik P Sulman, David D Eisenstat
No abstract text is available yet for this article.
2023: Frontiers in Oncology
https://read.qxmd.com/read/37646983/palliative-care-for-children-with-central-nervous-system-tumors-results-of-a-spanish-multicenter-study
#24
JOURNAL ARTICLE
Maria Pérez-Torres Lobato, Lucía Navarro-Marchena, Iñigo de Noriega, Miriam Morey Olivé, Palma Solano-Páez, Eloísa Rubio Pérez, Carmen Garrido Colino, Miriam García Abos, María Tallón García, Beatriz Huidobro Labarga, Raquel Portugal Rodríguez, Blanca López Ibor, Álvaro Lassaletta, Andrés Morgenstern Isaak, Ofelia Cruz Martínez, Lorena Valero Arrese, Anna Llort Sales, Luis Gros Subias, Catalina Márquez Vega, Lucas Moreno, Eduardo Quiroga-Cantero
BACKGROUND: Brain tumors represent the most common cause of cancer-related death in children. Few studies concerning the palliative phase in children with brain tumors are available. OBJECTIVES: (i) To describe the palliative phase in children with brain tumors; (ii) to determine whether the use of palliative sedation (PS) depends on the place of death, the age of the patient, or if they received specific palliative care (PC). METHODS: Retrospective multicenter study between 2010 and 2021, including children from one month to 18 years, who had died of a brain tumor...
August 30, 2023: Clinical & Translational Oncology
https://read.qxmd.com/read/37584191/ultrasound-guided-bilateral-pulsed-radiofrequency-of-the-phrenic-nerve-for-prolonged-hiccups-a-case-report
#25
JOURNAL ARTICLE
German William Rangel, Karina Ortega Agón, Daniela Rangel Santos, Juan Pablo Duran, Karol Nathalia Cabeza Diaz
Singultus is the sudden onset of erratic diaphragmatic and intercostal muscle contraction immediately followed by laryngeal closure. Pathophysiology involves afferent, central and efferent components. Bilateral phrenic nerve block was performed to a 46-year-old woman with a brain tumor with persistent hiccups, with initially positive response but later symptom recurrence. Bilateral pulsed radiofrequency of the phrenic nerve was performed guided by ultrasonography (US). In the follow-up, absence of hiccups was confirmed...
July 2023: Pain Management
https://read.qxmd.com/read/37370865/relevance-of-the-updated-recursive-partitioning-analysis-u-rpa-classification-in-the-contemporary-care-of-patients-with-brain-metastases
#26
JOURNAL ARTICLE
Camilo E Fadul, Guneet Sarai, Joseph A Bovi, Alissa A Thomas, Wendy Novicoff, Roger Anderson, Ryan F Amidon, Samantha Schuetz, Rohit Singh, Amy Chang, Ryan D Gentzler, Elizabeth M Gaughan, Jason P Sheehan
Patients with brain metastases (BMETS) need information about the prognosis and potential value of treatment options to make informed therapeutic decisions, but tools to predict survival in contemporary practice are scarce. We propose an Updated Recursive Partitioning Analysis (U-RPA) instrument to predict survival and benefit from brain-directed treatment (BDT) of contemporary patients. This was a retrospective analysis of patients with BMETS treated between 2017 and 2019. With survival as the primary endpoint, we calculated the U-RPA and generated estimates using Kaplan-Meier curves and hazard ratios...
June 20, 2023: Cancers
https://read.qxmd.com/read/37370783/improving-localized-radiotherapy-for-glioblastoma-via-small-molecule-inhibition-of-kif11
#27
JOURNAL ARTICLE
Miranda M Tallman, Abigail A Zalenski, Ian Stabl, Morgan S Schrock, Luke Kollin, Eliane de Jong, Kuntal De, Treg M Grubb, Matthew K Summers, Monica Venere
Glioblastoma, IDH-wild type (GBM) is the most common and lethal malignant primary brain tumor. Standard of care includes surgery, radiotherapy, and chemotherapy with the DNA alkylating agent temozolomide (TMZ). Despite these intensive efforts, current GBM therapy remains mainly palliative with only modest improvement achieved in overall survival. With regards to radiotherapy, GBM is ranked as one of the most radioresistant tumor types. In this study, we wanted to investigate if enriching cells in the most radiosensitive cell cycle phase, mitosis, could improve localized radiotherapy for GBM...
June 13, 2023: Cancers
https://read.qxmd.com/read/37357920/the-place-of-the-relative-at-the-time-of-the-announcement-of-cancer-progression-babel-a-mixed-methods-study
#28
JOURNAL ARTICLE
Isabelle Ingrand, Estelle Laurent, Thierry Lecomte, Oana Cojocarasu, Joëlle Egreteau, Albert Aleba, José Hureaux, Philippe Colombat, Emmanuel Gyan, Hugues Bourgeois
OBJECTIVES: This study aims to explore the place of the relative in these triadic consultations and how this influences communication. METHODS: A mixed-methods research strategy was used. Triadic consultations for the announcement of cancer progression were recorded and following the 3 participants completed questionnaires comprising mirror-items. Recordings and answers were further investigated in a few semi-structured interviews. Comparison of quantitative responses (questionnaires) used Wilcoxon's test for matched series...
June 26, 2023: Palliative & Supportive Care
https://read.qxmd.com/read/37291377/narrative-review-of-multidisciplinary-management-of-central-nervous-involvement-in-patients-with-her2-positive-metastatic-breast-cancer-focus-on-elderly-patients
#29
REVIEW
Elena Galve-Calvo, Alberto Alonso-Babarro, María Martínez-García, María Pi-Figueras, Gloria Villalba, Saioa Alonso, Jorge Contreras
The tumor biology of human epidermal growth factor receptor 2 (HER2)-positive breast cancer (BC) promotes the development of central nervous system (CNS) metastases, with 25% of patients with HER2-positive BC developing CNS metastases. Furthermore, the incidence of HER2-positive BC brain metastases has increased in the last decades, likely because of the improved survival with targeted therapies and better detection methods. Brain metastases are detrimental to quality of life and survival and represent a challenging clinical problem, particularly in elderly women, who comprise a substantial proportion of patients diagnosed with BC and often have comorbidities or an age-related decline in organ function...
August 2023: Advances in Therapy
https://read.qxmd.com/read/37277314/diffuse-intrinsic-pontine-gliomas-first-registry-effort-in-mexico
#30
JOURNAL ARTICLE
Julieta Robles-Castro, Ana Niembro-Zúñiga, Mariana Ortiz-Azpilcueta, Yadira Betanzos-Cabrera, Farina Arreguín-González, Gabriela Barrera-Villegas, Daniel Ortiz-Morales, José Benjamín Arroyo-Acosta, Marta Zapata-Tarrés
INTRODUCTION: Brainstem tumors comprise 10.9% of all brain tumors, and pediatric diffuse intrinsic pontine gliomas (DIPG) have a fatal prognosis. Some countries have developed national and international register databases to characterize their populations to aid clinical and public policy decisions. This study provides information regarding the clinical characteristics of a retrospective cohort of children with DIPG in México from 2001 to 2021, and assesses the proposed prognostic factors previously described for survival outcome...
June 5, 2023: Pediatric Blood & Cancer
https://read.qxmd.com/read/37243744/the-experience-of-interval-scans-for-adults-living-with-primary-malignant-brain-tumors
#31
JOURNAL ARTICLE
Florien W Boele, Sarah E Rudkin, Kate Absolom, Gary Latchford, Susan C Short, Thomas C Booth
PURPOSE: People with primary malignant brain tumors (PMBT) undergo anti-tumor treatment and are followed up with MRI interval scans. There are potential burdens and benefits to interval scanning, yet high-quality evidence to suggest whether scans are beneficial or alter outcomes of importance for patients is lacking. We aimed to gain an in-depth understanding of how adults living with PMBTs experience and cope with interval scanning. METHODS: Twelve patients diagnosed with WHO grade III or IV PMBT from two sites in the UK took part...
May 27, 2023: Supportive Care in Cancer
https://read.qxmd.com/read/37191815/depression-in-brain-tumor-patients-early-detection-and-screening
#32
JOURNAL ARTICLE
Alida Finze, Laura Deleanu, Christel Weiss, Miriam Ratliff, Marcel Seiz-Rosenhagen
BACKGROUND: Depres sion is reported in up to 90% of cancer patients but to this date, a standardized screening tool for depression specifically modified for patients diagnosed with brain tumors is lacking. Thus, this study aims to develop an adapted screening tool and identify a suitable time slot for screening. METHODS: Sixty-one patients with brain lesions were interviewed prior to neurosurgical resection. For screening purposes, established depression scores were used...
May 16, 2023: Supportive Care in Cancer
https://read.qxmd.com/read/37186374/multi-ligand-functionalized-blood-to-tumor-sequential-targeting-strategies-in-the-field-of-glioblastoma-nanomedicine
#33
REVIEW
Cláudia Martins, Bruno Sarmento
Glioblastoma (GBM) is an unmet clinical need characterized by a standard of care (SOC) 5-year survival rate of only 5%, and a treatment mostly palliative. Significant hurdles in GBM therapies include an effective penetration of therapeutics through the brain protective barrier, namely the blood-brain barrier (BBB), and a successful therapeutic delivery to brain-invading tumor cells post-BBB crossing. These hurdles, along with the poor prognosis and critical heterogeneity of the disease, have shifted attention to treatment modalities with capacity to precisely and sequentially target (i) BBB cells, inducing blood-to-brain transport, and (ii) GBM cells, leading to a higher therapeutic accumulation at the tumor site...
April 25, 2023: Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology
https://read.qxmd.com/read/37152484/clinical-factors-associated-with-30-day-mortality-among-patients-undergoing-radiation-therapy-for-brain-metastases
#34
JOURNAL ARTICLE
Divya Natesan, David J Carpenter, Will Giles, Taofik Oyekunle, Donna Niedzwiecki, Zachary J Reitman, John P Kirkpatrick, Scott R Floyd
PURPOSE: Existing brain metastasis prognostic models do not identify patients at risk of very poor survival after radiation therapy (RT). Identifying patient and disease risk factors for 30-day mortality (30-DM) after RT may help identify patients who would not benefit from RT. METHODS AND MATERIALS: All patients who received stereotactic radiosurgery (SRS) or whole-brain RT (WBRT) for brain metastases from January 1, 2017, to September 30, 2020, at a single tertiary care center were included...
2023: Advances in Radiation Oncology
https://read.qxmd.com/read/37151154/the-korean-society-for-neuro-oncology-ksno-guideline-for-the-management-of-brain-tumor-patients-during-the-crisis-period-a-consensus-recommendation-using-the-delphi-method-version-2023-1
#35
JOURNAL ARTICLE
Min-Sung Kim, Se-Il Go, Chan Woo Wee, Min Ho Lee, Seok-Gu Kang, Kyeong-O Go, Sae Min Kwon, Woohyun Kim, Yun-Sik Dho, Sung-Hye Park, Youngbeom Seo, Sang Woo Song, Stephen Ahn, Hyuk-Jin Oh, Hong In Yoon, Sea-Won Lee, Joo Ho Lee, Kyung Rae Cho, Jung Won Choi, Je Beom Hong, Kihwan Hwang, Chul-Kee Park, Do Hoon Lim
BACKGROUND: During the coronavirus disease 2019 (COVID-19) pandemic, the need for appropriate treatment guidelines for patients with brain tumors was indispensable due to the lack and limitations of medical resources. Thus, the Korean Society for Neuro-Oncology (KSNO), a multidisciplinary academic society, has undertaken efforts to develop a guideline that is tailored to the domestic situation and that can be used in similar crisis situations in the future. METHODS: The KSNO Guideline Working Group was composed of 22 multidisciplinary experts on neuro-oncology in Korea...
April 2023: Brain Tumor Research and Treatment
https://read.qxmd.com/read/37103675/investigate-the-possibility-of-using-phosphorescence-in-clinical-oncology-as-an-early-prognostic-test-in-detecting-brain-carcinogenesis
#36
JOURNAL ARTICLE
Yuriy O Vinnyk, Igor A Kryvoruchko, Valeriy V Boyko, Yulia V Ivanova, Svetlana Gramatiuk, Karine Sargsyan
Phosphorescence is considered one of the non-invasive glioblastoma testing methods based on studying molecular energy and the metabolism of L-tryptophan (Trp) through KP, which provides essential information on regulating immunity and neuronal function. This study aimed to conduct a feasibility study using phosphorescence in clinical oncology as an early prognostic test in detecting Glioblastoma. This study was conducted on 1039 patients who were operated on with follow-up between January 1, 2014, and December 1, 2022, and retrospectively evaluated in participating institutions in Ukraine (the Department of Oncology, Radiation Therapy, Oncosurgery, and Palliative Care at the Kharkiv National Medical University)...
April 27, 2023: Journal of Fluorescence
https://read.qxmd.com/read/37098001/reply-to-the-letter-regarding-palliative-care-and-end-of-life-care-in-adults-with-malignant-brain-tumors
#37
EDITORIAL
Johan A F Koekkoek, Pim B van der Meer, Tobias Walbert
No abstract text is available yet for this article.
April 25, 2023: Neuro-oncology
https://read.qxmd.com/read/37082500/gradual-and-remarkable-tumor-shrinkage-following-seven-fraction-stereotactic-radiosurgery-alone-with-a-marginal-dose-of-48-3-gy-for-large-lobar-possibly-intra-sulcal-brain-metastasis-from-renal-cell-carcinoma
#38
Kazuhiro Ohtakara, Sachiko Aoki, Manabu Tajima, Takato Ohno, Kojiro Suzuki
Brain metastases (BMs) from renal cell carcinoma (RCC) have the tendency of slow and insufficient tumor shrinkage along with prolongation of massive peritumoral edema following stereotactic radiosurgery (SRS). Herein, we describe a case of large lobar RCC-BM, with possible intra-sulcal location, treated with 7-fraction (fr) SRS without subsequent anti-cancer medication, which resulted in gradual and remarkable tumor shrinkage with extrication from the mass effect. A 59-year-old woman was incidentally diagnosed with bilateral RCC associated with multiple lung metastases and subsequently presented with symptomatic single BM of 32 mm in the maximum diameter (9...
March 2023: Curēus
https://read.qxmd.com/read/37032344/effect-of-palliative-care-decisions-making-on-hospital-service-use-at-end-of-life-in-patients-with-malignant-brain-tumors-a-retrospective-study
#39
JOURNAL ARTICLE
Nelli-Sofia Nåhls, Riikka-Leena Leskelä, Tiina Saarto, Outi Hirvonen, Anu Anttonen
BACKGROUND: Palliative care (PC) improves Quality of life and reduces the symptom burden. Aggressive treatments at end of life (EOL) postpone PC. The aim of this single-center retrospective study was to evaluate the timing of the PC decision i.e., termination of cancer-specific treatments and focusing on symptom-centered PC, and its impact on the use of tertiary hospital services at the EOL. METHODS: A retrospective cohort study on brain tumor patients, who were treated at the Comprehensive Cancer Center of the Helsinki University Hospital from November 1993 to December 2014 and died between January 2013 and December 2014, were retrospectively reviewed...
April 10, 2023: BMC Palliative Care
https://read.qxmd.com/read/37018427/single-session-gamma-knife-radiosurgery-for-patients-with-20-or-more-brain-metastases
#40
JOURNAL ARTICLE
Zhishuo Wei, Diego D Luy, Shalini Jose, Hansen Deng, Sila Yavan, Stephen Worrell, J Raouf Belkhir, Lilly W Tang, Ajay Niranjan, L Dade Lunsford
BACKGROUND: Stereotactic radiosurgery (SRS) is a widely accepted treatment modality for brain metastases. The role of SRS in patients with higher numbers of metastases remains controversial. OBJECTIVES: To define outcomes in patients with ≥20 brain metastases managed using single-session SRS. METHODS: This single-institution retrospective cohort study studied 75 patients (26 non-small-cell lung cancer, 21 small-cell lung cancer, 14 breast cancer, and 14 melanoma) undergoing single-session SRS...
April 5, 2023: Neurosurgery
keyword
keyword
8184
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.